We tested the hypothesis that increased systemic vascular resistance in spontaneously hypertensive rats may be secondary to enhanced phospholipase C activity in response to vasoconstrictor stimuli. Activation of phospholipase C by angiotensin 11 (Ang II), thromboxane A 2 , arginine vasopressin, and endothelin-1 was compared in cultured glomerular mesangial cells and mesenteric vascular smooth muscle cells taken from 13-to 14-week-old hypertensive and normotensive Wistar-Kyoto rats (blood pressure, 185 ±1 versus 135±2 mm Hg). Phospholipase C was assessed by measuring cytosolic free calcium and by the accumulation of radiolabeled inositol phosphates. Basal cytosolic calcium did not differ between mesangial cells taken from both strains but was greater in smooth muscle cells from hypertensive rats (210.1 ±8.2 versus 149.2±4.7 nM). The responsiveness of cytosolic calcium and inositol phosphate accumulation to Ang II was significantly enhanced in mesangial cells from hypertensive rats (10~7 M Ang II: peak increase of calcium, 1,266±181 versus 603±93 nM; percent increment of inositol phosphates at I minute, 266±26 versus 98±10%). Vascular smooth muscle cells from hypertensive rats, when compared with normotensive rats, showed a similar augmentation of Ang H-stimulated intracellular calcium and inositol phosphates. Thromboxane A^-induced enhancement of intracellular calcium and inositol phosphate accumulation in vascular smooth muscle cells was also greater in hypertensive animals. However, the responses to vasopressin and endothelin in mesangial or vascular smooth muscle cells did not differ between the normotensive and hypertensive animals. There was no significant difference in Ang II receptor number and affinity between hypertensive-and normotensive-derived mesangial cells. We conclude that genetically increased blood pressure in rats may be secondary to enhanced post-receptor signaling in glomerular mesangial cells activated by Ang II and to enhanced signaling in vascular smooth muscle cells stimulated by either Ang II or thromboxane A 2 . (Hypertension 1992; 19:446-455) KEY WORDS • calcium • inositol phosphates • vascular smooth muscle • mesangial cells • spontaneously hypertensive rats P hospholipase C (PLC) is a plasma membrane enzyme that hydrolyzes phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P 2 ] thereby releasing inositol 1, 4, 4, 5) P 3 ] to the cytosol, and diacylglycerol within the plane of the membrane.
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We tested the hypothesis that increased systemic vascular resistance in spontaneously hypertensive rats may be secondary to enhanced phospholipase C activity in response to vasoconstrictor stimuli. Activation of phospholipase C by angiotensin 11 (Ang II), thromboxane A 2 , arginine vasopressin, and endothelin-1 was compared in cultured glomerular mesangial cells and mesenteric vascular smooth muscle cells taken from 13-to 14-week-old hypertensive and normotensive Wistar-Kyoto rats (blood pressure, 185 ±1 versus 135±2 mm Hg). Phospholipase C was assessed by measuring cytosolic free calcium and by the accumulation of radiolabeled inositol phosphates. Basal cytosolic calcium did not differ between mesangial cells taken from both strains but was greater in smooth muscle cells from hypertensive rats (210.1 ±8.2 versus 149.2±4.7 nM). The responsiveness of cytosolic calcium and inositol phosphate accumulation to Ang II was significantly enhanced in mesangial cells from hypertensive rats (10~7 M Ang II: peak increase of calcium, 1,266±181 versus 603±93 nM; percent increment of inositol phosphates at I minute, 266±26 versus 98±10%). Vascular smooth muscle cells from hypertensive rats, when compared with normotensive rats, showed a similar augmentation of Ang H-stimulated intracellular calcium and inositol phosphates. Thromboxane A^-induced enhancement of intracellular calcium and inositol phosphate accumulation in vascular smooth muscle cells was also greater in hypertensive animals. However, the responses to vasopressin and endothelin in mesangial or vascular smooth muscle cells did not differ between the normotensive and hypertensive animals. There was no significant difference in Ang II receptor number and affinity between hypertensive-and normotensive-derived mesangial cells. We conclude that genetically increased blood pressure in rats may be secondary to 3 ] to the cytosol, and diacylglycerol within the plane of the membrane. 1 The primary function of Ins(l,4,5)P 3 is to mobilize Ca 2+ from intracellular stores, whereas diacylglycerol is required for the physiological activation of protein kinase C. Increased intracellular free Ca 2+ ([Ca 2+ ]j) elicits rapid contraction of smooth muscle and nonmuscle cells by myosin light-chain phosphorylation. 2 Activation of protein kinase C initiates slow but sustained vasoconstriction. 34 In the field of hypertension research, early observations of elevated [Ca 2+ ]; or a rapid turnover rate of phosphoinositides in spontaneously hypertensive rat (SHR)-derived platelets, 5 lymphocytes, 6 and red blood cells, 7 stimulated interest in vascular PLC activity, which may be more important in the regulation of arterial blood pressure. Enhanced PLC activity 8 and elevated [Ca 2+ ], 9 have been found under nonstimulated conditions in cultured aortic vascular smooth muscle cells (VSMCs) obtained from SHR. Because various vasoconstrictor agonists exert their effect in arterial VSMCs via an activation of PLC, receptor-mediated responsiveness of vascular PLC activity has also been investigated. One study 10 has shown that arginine vasopressin (AVP) evokes a greater increase in [Ca 2+ ]i in SHR than in Wistar-Kyoto (WKY) primary-cultured aortic VSMCs. Other evidence 11 " 13 has indicated that the responsiveness of PLC activity to angiotensin II (Ang II) or epidermal growth factor is enhanced in SHR-derived aortic VSMCs. Thus, many experiments have pointed to alterations of PLC activity in aortic VSMCs and circulating cells, but none of these tissues or cells regulate vascular resistance and blood pressure.
VSMCs from arterioles regulate the systemic vascular resistance, and the contraction of glomerular mesangial cells reduces glomerular filtration rate and ultrafiltration coefficient.
14 Since it still remains uncertain whether abnormalities observed in cells derived from large vessels and circulating blood cells are present in resistance vessels or glomerular mesangiai cells, we tested the hypothesis that increased systemic vascular resistance and decreased glomenilar filtration rate (GFR) in SHR may be secondary to enhanced PLC signaling of mesenteric resistance VSMCs and glomerular mesangial cells in response to vasoconstrictor stimuli. We report here that PLC signaling that is activated by Ang II is enhanced in mesenteric VSMCs and glomenilar mesangial cells from SHR by post-receptor mechanisms.
Methods

Materials
Ten SHR and 10 WKY rats (male, aged 13-14 weeks) were obtained from Charles River, Boston, Mass. Cell culture media were from Hazeleton Biologies, Lenexa, Kan.; fetal bovine serum (FBS) and bovine calf serum (BCS) were purchased from Hyclone, Logan, Utah. 
Cell Culture
Mesangial cells and mesenteric VSMCs were obtained from 10 ether-anesthetized male 13-to 14-weekold SHRs and 10 age-matched WKY rats. They were studied as five pairs of cells. Rat mesangial cells were grown from glomerular explants using a slightly modified technique from Striker et al. 15 Brass sieves (106 and 150 fim) were used for the initial separation of rat glomemli. Details on the isolation and propagation of the cells are published elsewhere. 1617 Cells were maintained in RPMI-1640 supplemented with 8.5% FBS, 8.5% BCS, 100 units/ml penicillin, 100 /ig/ml streptomycin, 5 jig/ml insulin, 5 yxg/ml transferrin, and 5 ng/ml selenium at 37°C in 5% COz-95% air. Mesangial cells were subcultured every 7-10 days using trypsin (0.05%)-EDTA (0.02%); media in all cultures were renewed every 2-3 days. Each mesangial cell line was characterized, as previously reported for rat mesangial cells. Rat mesenteric VSMCs were isolated by a digestive method. 18 The mesenteric arteries and their small vascular networks were taken out with the abdominal aorta. They were cleaned in balanced salt solution (in mM: NaCl 125, KC1 5, MgCl 2 3 (complete DMEM), the cells were passed through 125 -fim nitrex. After centrifugation at 200g for 10 minutes, the supernate was aspirated, and the VSMCs were resuspended in 3 ml fresh DMEM. Cells were maintained in complete DMEM at 37°C under 5% CO 2 -95% air. Mesenteric VSMCs were subcultured every 5-7 days using trypsin (0.05%)-EDTA (0.02%), and media in all cultures were renewed every 3-4 days. Each cell line was characterized by immunocytochemical study of a-smooth muscle cell actin. For the present study, we used mesangial cells from the second to the seventh passages and mesenteric VSMCs from the first to the fifth passages. Each experiment was performed using cells of the same passage number that were maintained under the same conditions after the final subculture.
Immunocytochemical Studies
To distinguish VSMCs from fibroblasts and endothelial cells, a-smooth muscle cell actin staining was performed on cells obtained from rat mesenteric arteries. 19 The cells were stained for 90 minutes at 37°C with monoclonal anti-a-smooth muscle actin (1:400) diluted in Dulbecco's phosphate-buffered saline (DPBS) containing 1% BSA or DPBS alone (negative control). Then the cells were incubated for 60 minutes at room temperature with goat anti-mouse immunoglobulin G horseradish peroxidase. Figure 1 shows fine staining of a-smooth muscle cell actin in mesenteric VSMCs.
Measurement of [Ca
2+
], Intracellular [Ca 2+ ]! was determined with the Ca 2+ -sensitive dye fura-2 after the cells were incubated for 24 hours in serum-free media. As reported, 20 confluent mesangial cell monolayers on plastic Aclar coverslips were loaded with 1 JAM fura-2 in RPMI-1640 for 40 minutes at 37°C, then washed twice and incubated again for 20 minutes in RPMI, free of fura-2, to allow for intracellular dye cleavage. Confluent mesenteric VSMC monolayers were loaded with 5 /xM fura-2 in serum-free DMEM for 20 minutes at 37°C. The coverslips were mounted in a quartz cuvette with 2 ml Krebs-Henseleit HEPES (KHH), pH 7.4, maintained at 37°C with constant stirring. [Ca 2+ ]| was determined by measuring fluorescence with a University of Pennsylvania Biomedical Instruments Group spectrophotometer at 340 and 380 nm excitation and 510 nm emission. Fluorescence measurements (F) were converted to Ca 2+ concentrations by determining maximal fluorescence (F^,) with 25-50 fiM ionomycin followed by minimal fluorescence (Fnrf,,) with 7.5 mM ethylene glycol bisO-aminoethyl ether)-Af,iV,W,W-tetraacetic acid (EGTA), and 60 mM Tris, pH 10.5. The following formula was then used:
Ki for fura-2 is 224 nM. Autofluorescence by the cells or agonists was negligible. To study the alterations in [Ca the dose-dependent [Ca 2+ ], responses to Ang II, AVP, ET-1, and U46619 were compared between SHR and WKY rats. In addition, the mechanism for the increase in [Ca 2+ ]i in response to 10" 7 M Ang II was investigated in mesangial cells taken from SHR and WKY rats, using Ca 2+ -free KHH, Ca 2+ -free KHH with 4 mM EGTA, 30 /xM nifedipine, and high potassium (30 mM).
Measurement of Inositol Phosphates
Inositol phosphate was measured after myo-[ 3 H]inositol incorporation into confluent monolayers of rat mesangial cells and mesenteric VSMCs, followed by perchlorate extraction and separation by anion exchange chromatography. 20 Cells grown in 12-weIl dishes (approximately 20,000 cells per well) were incubated for 40-44 hours with 5 /tCi/ml myo-[2-3 H(jV)]inositol in serum-free RPMI-1640 without inositol. The medium was then removed, and the monolayers were washed three times with PBS, pH 7.4, and incubated in KHH at 37°C supplemented with 10 mM LiCl and vasoconstrictor agonists in various concentrations. Incubations were terminated by the addition of 120 u\ of 3.3N perchloric acid (PCA), and the dishes were immediately placed on ice for 15 minutes. The monolayers were scraped off with a rubber policeman and transferred to plastic microcentrifuge tubes; the extracts were pooled with an additional rinse of the wells with 480 y\ of 0.55N PCA and were centrifuged for 5 minutes at 10,000g. One ml of the supernate was neutralized with 55 u\ of ION KOH, and after 15 minutes on ice, the precipitated PCA extract was pelleted by centrifugation. One-milliliter aliquots of the neutralized supernates were diluted with 9 ml of 5 mM sodium tetraborate and applied onto prewashed 0.8-ml columns packed with AG1X8 (200-400 mesh) formate anion exchange resin. The columns were rinsed twice with 12 ml of a 60 mM sodium formate-5 mM tetraborate solution, and the inositol phosphates were eluted sequentially with 0.2, 0.4, and 1 M NH* formate in 0.1 M formic acid for inositol monophosphate (InsP), inositol bisphosphate (InsP 2 ), and inositol trisphosphate (InsP 3 ), respectively. This technique does not allow for separation of Ins(l,4^)P 3 and inositol 1,3,4-trisphosphate [Ins(l,3,4)P 3 ]. Each eluate was collected directly in plastic scintillation vials, evaporated to dryness by vacuum centrifugation in a Savant Speed-Vac 200 apparatus, redissolved in 1 ml distilled water, and mixed with 9 ml Formula 963 counting fluid (New England Nuclear) for liquid scintillation counting.
I-Angiotensin II Binding Assays
125
I-Ang II binding assays were carried out by using membranes from mesangial cells. Confluent monolayers in 100-mm Petri dishes were washed twice with HBSS at 4°C. All subsequent procedures were performed at 4°C. Each monolayer was then scraped into 25 ml HBSS. Suspended cells were centrifuged twice at 500g for 5 minutes with an intermediate resuspension in 25 ml HBSS and then homogenized in 2 ml of ice-cold Trissucrose buffer (270 mM sucrose buffered with 50 mM Tris-HCl, pH 7.4) using a Teflon-glass homogenizer (five passes at 1,000 rpm). The homogenate was centrifuged in 15 ml Tris-sucrose buffer at 500g for 10 minutes, and the pellet was discarded. The supernate was centrifuged at 40,000g for 15 minutes, and the pellet was washed two more times at 40,000g, once in 50 mM Tris-HCl buffer (pH 7.7) containing 5.0 mM EDTA, and once in EDTA-free Tris-HCl. The resulting pellets were stored at -80°C. The protein content of the membrane fractions was measured spectrophotometrically. The standard assay mixture contained 25 yX 12S I-Ang II (0.25-0.5 nM), 100 fi\ 50 mM Tris-HCl, pH 7.4 (120 mM NaCl, 5 mM MgCl 2 , 0.55% BSA, 0.004% bacitracin) with unlabeled Ang II (10~1 0 to lO" 6 M) and 125 fi\ membrane preparation (25-50 ^g) in 16x 100-mm glass tubes at room temperature. After incubating for 60 minutes, bound and free radioligand were separated by rapidly diluting a 250 y\ aliquot of the incubation mixture in 2.0 ml of 50 mM Tris-HCl, pH 7.4, supplemented with 120 mM NaCl and 5 mM MgCl 2 (wash buffer), at 4°C and then immediately filtering through presoaked Whatman GF/B glass-fiber filters. Each filter was rapidly washed with 20 ml ice-cold wash buffer and counted in a gamma counter. Nonspecific binding was assessed by incubating the membranes in the presence of 10"* M unlabeled Ang II and was found to be 28.3±3.6% of total binding in WKY rats and 23.4±4.1% in SHR. Specific binding was then determined by subtracting nonspecific from total binding. Competitive displacement studies were analyzed as described by Cheng and Prusoff. 21 
Plasma Membrane Phospholipase C Assays
Membrane PLC activity of mesangial cells was measured using exogenous PtdIns(4,5)P 2 . 22 The following components were added to the PLC assay: 50 mM HEPES, pH 7.0, 0.1 mM CaCl, 9 mM sodium cholate, The reaction mixture was incubated for 20 minutes at 37°C, and the reaction was stopped with 1 ml chloroform/methanol/concentrated HC1 (100:100:0.6) followed by 0.3 ml of IN HC1 containing 5 mM EGTA. After extraction, a 400 fi\ portion of the aqueous phase was removed for liquid scintillation counting. Under these assay conditions, the PLC activities were linear with respect to time and protein concentration.
Statistics
Results are presented as mean±SEM. Comparisons were made using two-way analysis of variance (ANOVA) and unpaired / test
Results
Blood Pressure
Systolic blood pressures were measured by the tailcuff method before the rats were killed, and the values were 135±2 mm Hg for WKY rats (« = 10) and 185±1 mm Hg for SHR (n = 10) (/><0.001). ]j. Characteristically, the sustained increase induced by U46619 lasted longer than that induced by the other three agonists. Figure 5 shows the dose-dependency of Ang II-AVP-, U46619-, and ET- influx depends on nifedipine-insensitive and voltageindependent Ca 2+ channels in these primary cultures.
FIGURE 5. Line plots show dose-dependency of angiotensin II (Ang II), arginine vasopressin (AVP), U46619, and endothelin-1 (ET-1)-induced changes of intracellular calcium concentration ([Ca
2+ JJ in mesangial cells and mesenteric vascular smooth muscle cells (VSMCs). Data are mean ±SEM for five to seven monolayers in different experiments
Inositol Phosphate Studies
Initially, we investigated the temporal pattern of InsP, InsP 2 , and InsP 3 formation in response to 10" 7 M Ang II in SHR and WKY rats. As shown in Figure 6 , in mesangial cells a slow increase in InsP accumulation started at 1 minute and plateaued between 5 and 15 minutes. InsP release was 20-30% greater in SHR cells at 15 seconds and 1 minute, but the entire time course did not differ between SHR and WKY rats by two-way ANOVA. In contrast to the temporal pattern of InsP, Ang II at 10~7 M elicited a rapid accumulation of InsP 2 and InsP 3 within 15 seconds. These rapid rises of InsP 2 and InsP 3 reached a maximum at 1 minute after the exposure to Ang II and were followed by a rapid decline toward the basal level. The time course of accumulation of InsP 2 and InsP 3 in mesangial cells was significantly greater in SHR than in WKY rats (two-way ANOVA: InsP 2 and InsP 3 , /?<0.05). In mesenteric VSMCs, as illustrated in Figure 7 , an increase in InsP accumulation in response to 10~7 Ang II occurred at 1 minute and plateaued between 5 and 15 minutes. Tune-dependent InsP accumulation was greater in SHR (two-way ANOVA, p<0.05). Ang II elicited a rapid accumulation of InsP 2 phates. Figure 8 shows the dose-dependency of Ang II-induced phosphoinositide catabolism in mesangial cells. Dose-dependent release of InsP, InsPz, InsPj, and total inositol phosphates was greater in SHR than in WKY rats (two-way ANOVA, /?<0.05 for each), and these differences were clear between 10"' and 10~7 M Ang II. The threshold of InsP 3 accumulation was between 10" 10 and 10" 9 M in SHR, and between 1(T 9 and 10" 8 M in WKY rats. Figure 9 shows that release of inositol phosphates from mesenteric VSMCs stimulated with Ang II is dose-dependent. Dose-dependent release of InsP, InsPÎ nsP 3 , and total inositol phosphates was greater in VSMCs from SHR than from WKY rats (two-way ANOVA, /?<0.05 for each). As illustrated in Figure 10 , U46619-induced InsP, InsP^ InsP 3 , and total inositol phosphates accumulation of SHR-derived mesenteric VSMCs was enhanced only at 10"* M (p<0.05, unpaired / test). We also measured the turnover of inositol phosphates in mesangial cells and VSMCs of SHR and WKY rats after stimulation with ET-1 and AVP (Table 1) . ET-1 and AVP elicited similar increments of inositol phosphates in mesangial cells and VSMCs from SHR and WKY rats. The numerically greater responses of SHR mesangial cells were not statistically different from WKY rats. As noted above ( Figure 5 ), ET-1 and AVP did not elicit exaggerated [Ca 2+ ], responses in either SHR mesangial cells or VSMCs. Using [ and showed lower values for K m in mesangial membranes of SHR cells (34.2±0.8 nM) than in those of WKY rats (94.1±8.5 nM) (n=3;p<0.01, unpaired / test). There were no differences in maximal velocity.
1-Angiotensin II Binding Assays
To assess whether differences in Ang II binding capacity exist between cultured SHR and WKY mesangial cells, their surface Ang II receptor density was measured. Binding data from four experiments are displayed in Table 2 and Figure 11 . In both strains significant displacement of radioligand was observed at 10"' M unlabeled Ang II, and maximum displacement was seen at 10" 7J M. The shape of the competitive displacement curve was exactly the same between SHR and WKY rats. As estimated by the method of Cheng and Prusoff, 21 the K4 for the Ang II receptor was the same for SHR and WKY rats. Although SHR showed a slightly greater receptor number than did WKY rats, there was no significant interstrain difference in maximum binding.
Discussion
Several publications 8 -12 have documented enhanced PLC activity in VSMCs derived from large conduit vessels, i.e., the aorta. We questioned whether similar changes are present in resistance VSMCs and glomerular mesangial cells, which are modified vascular peri- As demonstrated in coarctation-induced hypertension, 27 elevation of blood pressure in SHR may cause secondary enhancement of inositol phosphate formation. However, since increased PLC activity and increased [Ca 2+ ]j are already observed in prehypertensive ]i, may be secondary to a specific, genetic alteration of the G protein linking the Ang II receptor to PLC. It is unknown whether different isoforms of G proteins associate diverse receptors to PLC. It is also possible that the genetic defect leading to hypertension in SHR is in the PLC linked to specific receptors (i.e., Ang II). Our experiments with mesangial cell plasma membranes as well as previously published data support the belief that PLC enzymatic activity is greater in cells from SHR than in those from WKY rats. We do not know whether there are differences of PLC isotypes between these rat species. In addition to G protein and PLC itself, the PLC regulatory proteins 40 -41 and the amount of PtdIns(4,5)P 2 in the plasma membrane could also affect the activity of PLC. However, these explanations fail to explain the specificity of agonist-induced PLC hyperresponsrveness.
The Ang II-induced increases of inositol phosphates in SHR mesangial cells and VSMCs, compared with WKY cells, appeared at lower threshold concentrations of Ang II (Figures 8 and 9 ) than the enhanced responsiveness of [Ca 2+ ], to Ang II ( Figure 5 ). It should be emphasized that we measured mesangial inositol phosphates at 1 minute, VSMC inositol phosphates at 5 minutes, and peak [Ca 2+ ], at variable times ranging from 15 to 30 seconds (high concentrations of Ang II) to 1-2 minutes (Ang II 0.1-1.0 nM). In addition, SHR cells may have an augmented calcium efflux across the plasma membrane, thereby attenuating the PLC-dependent increments of [Ca 2+ ]i in response to Ang II (T. Osanai and M.J. Dunn, unpublished observations).
Enhanced responsiveness of VSMCs and glomerular mesangial cells to vasoconstrictor stimuli may increase blood pressure acutely and chronically. Acutely, Ang II may cause greater contraction of resistance arterioles, thereby altering total peripheral resistance. Chronically, greater proliferation of SHR VSMCs in response to Ang II would lead to medial hyperplasia and hypertrophy thereby reducing arteriolar lumenal diameter. In addition, mesangial contraction reduces glomerular filtration rate through decrements of glomerular filtration surface area thereby possibly augmenting positive sodium and volume balances.
We conclude that increased blood pressure in SHR may be secondary to enhanced post-receptor signaling of glomerular mesangial cells activated by Ang II and of VSMCs activated by Ang II and TXA 2 .
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